Virpax Pharmaceuticals Inc
The VRPX stock trades on Nasdaq All Markets
Company Description
Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate.
Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline. Virpax® Pharmaceuticals (Nasdaq: VRPX) is a publicly held specialty pharmaceutical company located in Berwyn, PA and is focused on advancing the development and worldwide commercialization of its non-addictive pain and neurological disorder pipeline.
Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline. Virpax® Pharmaceuticals (Nasdaq: VRPX) is a publicly held specialty pharmaceutical company located in Berwyn, PA and is focused on advancing the development and worldwide commercialization of its non-addictive pain and neurological disorder pipeline.
Technology
Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate.
Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline.
Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline.
Drug Pipeline
Source: Virpax Pharmaceuticals Inc - 20221129
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
AnQlar
COVID-19
Preclinical
Influenza
Preclinical
Envelta
Pain
Preclinical
Epoladerm
Pain
Phase 1
Probudur
Pain Management
Preclinical
VRP324
Epilepsy
Preclinical
0 Comments on VRPX stock
Newest
Conversation